As the phase1b study has already indicated that ptx100 is safe and more effective than currently available treatment options, why couldn't the phase2 study be granted registrational status from the beginning?
Ann: March 2024 Quarterly Update and Appendix 4C, page-25
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 4.0¢ | 3.9¢ | $35.17K | 896.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 350000 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 163887 | 2 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| PTX (ASX) Chart |